Phase II trial of celecoxib plus cisplatin and vinorelbine for first-line therapy in stage IIIB/IV non-small cell lung cancer
Latest Information Update: 29 Jul 2014
At a glance
- Drugs Celecoxib (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 05 Oct 2011 New trial record